Free Trial

Theratechnologies (THTX) SEC Filings & 10K Form

Theratechnologies logo
$3.42 +0.03 (+0.86%)
Closing price 09/25/2025
Extended Trading
$3.42 0.00 (0.00%)
As of 09/25/2025 06:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Theratechnologies SEC Filings

DateFilerForm TypeView
09/29/2025
3:30 PM
SUMMER ROAD LLC (Filed by)
Theratechnologies (Subject)
Form SCHEDULE 13G
09/25/2025
3:08 PM
Nasdaq Stock Market LLC (Filed by)
Theratechnologies (Subject)
Form 25-NSE
09/25/2025
1:02 PM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/17/2025
9:10 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/12/2025
3:22 PM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/12/2025
1:07 PM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/05/2025
2:32 PM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/02/2025
12:26 PM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/18/2025
6:52 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/18/2025
7:15 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/10/2025
10:07 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/09/2025
9:04 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/09/2025
9:11 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/09/2025
8:01 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/09/2025
7:35 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/03/2025
1:09 PM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/29/2025
1:31 PM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/02/2025
3:30 PM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/16/2025
9:51 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/15/2025
10:47 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/11/2025
6:30 PM
Soleus Capital Master Fund, L.P. (Filed by)
Theratechnologies (Subject)
Form SCHEDULE 13D/A
04/09/2025
8:51 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/09/2025
8:22 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/08/2025
10:13 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/01/2025
12:09 PM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/26/2025
11:52 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/26/2025
7:32 AM
Theratechnologies (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
02/26/2025
7:30 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/21/2025
3:37 PM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2025
2:21 PM
MORGAN STANLEY (Filed by)
Theratechnologies (Subject)
Form SCHEDULE 13G/A
02/14/2025
10:12 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2025
9:51 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/10/2025
7:24 AM
HIRSCHMAN ORIN (Filed by)
Theratechnologies (Subject)
Form SCHEDULE 13G/A
01/10/2025
6:01 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/12/2024
10:58 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/11/2024
5:01 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/09/2024
1:35 PM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/05/2024
9:43 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/04/2024
10:44 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/04/2024
7:53 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/02/2024
9:20 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/26/2024
10:41 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/14/2024
3:53 PM
Nantahala Capital Management, LLC (Filed by)
Theratechnologies (Subject)
Form SCHEDULE 13G/A
10/10/2024
7:36 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/10/2024
7:31 AM
Theratechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:THTX) was last updated on 10/9/2025 by MarketBeat.com Staff
From Our Partners